Thursday, 27 November 2025
  
Login

Australia's most trusted
source of pharma news

Thursday, 27 November 2025
Vivacity
Vivacity
Latest News
First pharma worth a trillion dollars

Hard to believe but in 2017 this pharma was worth US$81 billion but now its market cap has stretched to an eye-watering 13 figures for the first time - with even more growth on the horizon.

Novartis trailblazes private scripts
Streamlined system to supply non-PBS subsidised drugs into the hospital system launches with Novartis the first pharma on board
TODAY
Data void hid half of MBC patients
New world-first figures reveal the number of people living with this incurable disease in Australia are twice previous estimates
TODAY
Most Popular
Australia's Most Valued pharma is...
Aussie GPs and Specialists were asked to name the companies they valued the most, with one a standout performer
26 November
GM says goodbye but where's he going?
Leaving a remarkable legacy, this boss offers his team heartfelt thanks but there's still no word on his next move
26 November
Doctor calls out $7 Rep sandwich
Critics flamed for questioning the integrity of doctors who accept a pen or a meal alongside pharma medical education
25 November
Billion dollar 'No' for Lilly drug
A DNA test to determine eligibility for the first disease modifying treatment for this disease was turned down by MSAC
25 November
Latest Jobs
Pharma in Focus  Jobs

Sales & Customer Relations (16)

Clinical & Medical, R&D (8)

Regulatory, Pharmacovigilance & QA (3)

Executive Roles (3)

Other (15)

More News
Aussie trailblazer lands Novo prize
Seven finalists plus the winner of the inaugural Marie Krogh Prize for Young Women in Science take home $85K in prize money
26 November
TGA bumps up safety warning
70 adverse events linked to discontinued or delayed treatment of this popular PBS drug after a comprehensive investigation
26 November
Early detection avoids ER crisis
New report advocates for expansion of screening trial to avoid a medical emergency for 25,000 Aussies
26 November
Compounders target Novartis again
Pharma leapfrogged by a compounder to government funding for a copycat that does not have TGA approval
25 November
Omico warns of mates left behind
Precision oncology can extend life expectancy by half, but only one in five Aussies have access through the current referral system
25 November
Combo proves 'practice-changing'
FDA approves a big-name combo as the first perioperative treatment that improves survival for some types of bladder cancer
25 November
Who'll nab 2025's last PBS listings?
December PBS listings will mark the final reimbursement wins for 2025 and a dozen drugs are jostling for success
24 November
Three blockbusters-to-be hit TGA
Drugs with big sales predictions, including a mega-blockbuster, have landed on the ARTG in a busy week for approvals
24 November Approvals Action
'Fiasco sale' damages deal-making
With the Treasurer handing a US pharma a 'get out of jail free' card, questions are being asked how it will affect future pharma deals in Australia
24 November
AbbVie lifts lid on cancer burden
New report exposes urgent need to address the heavy toll inflicted on patients, families, communities and the economy
24 November
First 'Trojan Horse' drug wins nod
First-in-class drug ticked by the Regulator unlocks a new way of treating blood cancers, killing diseased cells from the inside
24 November
$275 blunder opens huge market
Who forgot to pay a tiny patent maintenance fee, paving the way for generics to enter the monster obesity market?
21 November
AI threat no one is talking about
Australian pharma coach is warning of a deeper disruption to the workplace than job losses if guardrails aren't put in place
21 November
Pharma votes for Best Workplace
ICYMI: See which company has been ranked the best place to work by pharma professionals plus the other top stories this week
21 November Your Week in 5 Minutes
PiF Jobs
PiF Jobs
© 2003 - 2025 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe